These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 583251)

  • 21. [On the determination of triamterene, hydroxythiamterene and hydroxytriamterene sulphate ester in biologica material by direct evaluation of thin-layer chromatograms (author's transl)].
    Grebian B; Geissler HE; Mutschler E
    Arzneimittelforschung; 1976; 26(12):2125-7. PubMed ID: 1037260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative studies of dihydrofolate reductase.
    Burchall JJ
    Postgrad Med J; 1969 Nov; 45():Suppl:29-32. PubMed ID: 5361306
    [No Abstract]   [Full Text] [Related]  

  • 23. Regulation of human dihydrofolate reductase activity and expression.
    Abali EE; Skacel NE; Celikkaya H; Hsieh YC
    Vitam Horm; 2008; 79():267-92. PubMed ID: 18804698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dihydrofolic reductase in human blood cells. I. Techniques for the study of enzyme activity and intracellular amethopterin content.
    Martelli MF; Tonato M; Grignani F
    Enzymol Biol Clin (Basel); 1967; 8(5):353-62. PubMed ID: 4383611
    [No Abstract]   [Full Text] [Related]  

  • 25. [Inhibitors of folic acid metabolism (author's transl)].
    Drews J
    Infection; 1980; 8 Suppl 3():S 268-75. PubMed ID: 6997204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Competitive dihydrofolate reductase binding assay of triazinate (NSC-139105), methasquin (NSC-122870), and aminopterin (NSC739).
    Myers CE; Eliot HM; Chabner BA
    Cancer Treat Rep; 1976 May; 60(5):615-6. PubMed ID: 1033031
    [No Abstract]   [Full Text] [Related]  

  • 27. [NADP analogs, inhibitors of dihydrofolate reductase].
    Belousova AK; Zilber IuA
    Biokhimiia; 1973; 38(5):1083-8. PubMed ID: 4149967
    [No Abstract]   [Full Text] [Related]  

  • 28. [Animal experimental and human pharmacologic studies with phase-II metabolites of triamterene].
    Völger KD
    Arzneimittelforschung; 1991 May; 41(5):499-506. PubMed ID: 1898420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicity of methotrexate and metoprine in a dihydrofolate reductase gene-amplified mouse cell line.
    Hamrell M; Laszlo J; Brown OE; Sedwick WD
    Mol Pharmacol; 1981 Nov; 20(3):637-43. PubMed ID: 7329406
    [No Abstract]   [Full Text] [Related]  

  • 30. Plasmodium berghei dihydrofolate reductase. Isolation, properties, and inhibition by antifolates.
    Ferone R; Burchall JJ; Hitchings GH
    Mol Pharmacol; 1969 Jan; 5(1):49-59. PubMed ID: 4392112
    [No Abstract]   [Full Text] [Related]  

  • 31. Dihydrofolate reductase from Trypanosoma equiperdum. I. Isolation, partial purification, and properties.
    Jaffe JJ; McCormack JJ
    Mol Pharmacol; 1967 Jul; 3(4):359-69. PubMed ID: 4382281
    [No Abstract]   [Full Text] [Related]  

  • 32. Biochemical factors in the selectivity of leucovorin rescue: selective inhibition of leucovorin reactivation of dihydrofolate reductase and leucovorin utilization in purine and pyrimidine biosynthesis by methotrexate and dihydrofolate polyglutamates.
    Goldman ID; Matherly LH
    NCI Monogr; 1987; (5):17-26. PubMed ID: 2448654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the cellular oxidation-reduction state in methotrexate binding to dihydrofolate reductase and dissociation induced by reduced folates.
    Matherly LH; Anderson LA; Goldman ID
    Cancer Res; 1984 Jun; 44(6):2325-30. PubMed ID: 6609765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dihydrofolate reductase from baker's yeast. Purification and properties].
    Nagelschmidt M; Jaenicke L
    Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):773-81. PubMed ID: 4403556
    [No Abstract]   [Full Text] [Related]  

  • 35. On the specificity of a histochemical method for localizing dihydrofolate dehydrogenase.
    Onicescu D; Popescu M; Tasca L; Stoica I
    Histochem J; 1972 Mar; 4(2):87-90. PubMed ID: 4339489
    [No Abstract]   [Full Text] [Related]  

  • 36. [Distribution volume and elimination of triamterene and its active metabolites in the rabbit (author's transl)].
    Knauf H; Mutschler E; Wais S; Wais U
    Arzneimittelforschung; 1978; 28(8):1414-6. PubMed ID: 582408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary levels of kynurenine and 3-hydroxykynurenine in the rat: effects of triamterene.
    Ghosh D; Green R
    Biochem Biophys Res Commun; 1970 Dec; 41(6):1421-8. PubMed ID: 5487869
    [No Abstract]   [Full Text] [Related]  

  • 38. Abnormal urinary sediment in patients on triamterene.
    Fairley KF; Birch DF; Haines I
    Lancet; 1983 Feb; 1(8321):421-2. PubMed ID: 6130414
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chemoluminescence of triamterene].
    Brandl H
    Pharm Unserer Zeit; 1986 Jul; 15(4):120-2. PubMed ID: 3749213
    [No Abstract]   [Full Text] [Related]  

  • 40. [Inhibition of human leukocytes dihydrofolate reductase by triamterene and its metabolites (author's transl)].
    Schalhorn A; Wilmanns W
    Arzneimittelforschung; 1979; 29(9):1409-11. PubMed ID: 583251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.